Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Hans GainesPublic Health Agency of Sweden, Solna, ;Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, ;Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Correspondence[email protected]

Jan AlbertDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, ;Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, ;Swedish Reference Group for Antiviral Therapy, Stockholm,

Maria AxelssonPublic Health Agency of Sweden, Solna,

Torsten BerglundPublic Health Agency of Sweden, Solna,

Magnus GisslénSwedish Reference Group for Antiviral Therapy, Stockholm, ;Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg,

Anders SönnerborgDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, ;Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, ;Swedish Reference Group for Antiviral Therapy, Stockholm, ;Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm,

Anders BlaxhultDepartment of Infectious Diseases, Södersjukhuset Venhälsan, Stockholm,

Gordana BogdanovicDepartment of Clinical Microbiology, Karolinska University Hospital, Stockholm,

Maria BryttingPublic Health Agency of Sweden, Solna,

Christina CarlanderSwedish Reference Group for Antiviral Therapy, Stockholm, ;Clinic of Infectious Diseases, County Hospital of Västmanland, Västerås,

Leo FlamholcSwedish Reference Group for Antiviral Therapy, Stockholm, ;Department of Infectious Diseases, University of Lund, Skåne University Hospital, Malmö,

Per FollinDepartment of Communicable Disease Control and Prevention, Region Västra Götaland, Gothenburg,

Axana HaggarNational Board of Health and Welfare, Stockholm,

Per HagstamDepartment of Communicable Disease Control and Prevention, Skåne, Malmö,

Marcus JohanssonDepartment of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital, Kalmar,

Lars NavérSwedish Reference Group for Antiviral Therapy, Stockholm, ;Department of Pediatrics, Karolinska University Hospital, Stockholm, ;Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm,

Jenny Persson blomSwedish Work Environment Authority, Stockholm, and

Agneta SamuelsonDepartment of Clinical Microbiology, Karolinska University Hospital, Stockholm,

Helena StrömNational Board of Health and Welfare, Stockholm,

Martin SundqvistDepartment of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden

Veronica Svedhem johanssonDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm,

Karin Tegmark wisellPublic Health Agency of Sweden, Solna,

Anders TegnellPublic Health Agency of Sweden, Solna,

Rigmor ThorstenssonPublic Health Agency of Sweden, Solna,

show all

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date